Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Coagulo Medical Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Coagulo Medical Technologies

Coagulo Medical Technologies

Coagulo Medical Technologies: Revolutionizing medicine with a portable, connected precision-medicine platform.

HQ
Auburndale, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Coagulo Medical Technologies is revolutionizing medicine with a portable, connected precision-medicine platform designed for the twenty-first century. The company's core mission is to lead the evolution of personalized coagulation management by introducing the world’s first platform capable of pinpointing abnormalities across the entire clotting cascade. This technology provides clinically valuable information that no other existing technology offers, focusing on precision management of coagulation.

Coagulo Medical Technologies has made significant strides in transforming how coagulation disorders are diagnosed and managed. By offering a portable solution that delivers unparalleled clinical insights, the company is setting new standards in the medical field. This innovative approach not only enhances patient outcomes but also supports healthcare providers in making more informed decisions.

Coagulo Medical Technologies - Similar Companies

Coagulation Sciences logo

Coagulation Sciences

iFirst Medical Technologies logo

iFirst Medical Technologies

ifirstmedtech.com

Abram Scientific logo

Abram Scientific

Perosphere Technologies logo

Perosphere Technologies

perospheretech.com

XaTek logo

XaTek

clotchip.com

MobileMedTek logo

MobileMedTek

ThromboVision logo

ThromboVision

Collaborative Medical Technology logo

Collaborative Medical Technology

Cognition Medical logo

Cognition Medical

Emergency Medical Innovation logo

Emergency Medical Innovation

CoapTech logo

CoapTech

coaptech.com

Majelco Medical logo

Majelco Medical

majelcomedical.com

Stasys logo

Stasys

stasysmedical.com

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Exactus logo

Exactus

Coagulo Medical Technologies - Quick Facts

Who are Coagulo Medical Technologies' competitors?

Companies similar to Coagulo Medical Technologies include Coagulation Sciences, iFirst Medical Technologies, Abram Scientific and Perosphere Technologies.

When was Coagulo Medical Technologies founded?

Coagulo Medical Technologies was founded in 2018.

Where is Coagulo Medical Technologies' headquarters located?

Coagulo Medical Technologies' headquarters is located in Auburndale, MA, US.

When was Coagulo Medical Technologies' last funding round?

Coagulo Medical Technologies' most recent funding round was for $6.5M (USD) in December 2020.

How much has Coagulo Medical Technologies raised to-date?

As of Dec 22, 2020, Coagulo Medical Technologies has raised a total of $6.8M (USD).

How many employees does Coagulo Medical Technologies have?

Coagulo Medical Technologies has 9 employees as of Feb 4, 2024.

Coagulo Medical Technologies - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Analytics
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • Medical Device
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities